ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-04-25 5:35:52 PM | Chg. +8.55 | Volume | Bid2024-04-25 | Ask5:35:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
141.15EUR | +6.45% | 46,155 Turnover: 6.48 mill. |
-Bid Size: - | -Ask Size: - | 217.64 bill.EUR | - | - |
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...